Fundraising Fox
Lucy Therapeutics
Cambridge, US · Founded 2017 · Delaware corporation · 3 employees on LinkedIn · 2 known investors
Find your way into Lucy Therapeutics
Sign up to see every warm intro you have to Lucy Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lucy Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Lucy Therapeutics was founded in 2017 by Amy Ripka.
AR
Amy RipkaCEO & FounderShe has spent over two decades in drug discovery across multiple therapeutic areas, holding scientific and executive leadership roles at companies including Infinity Pharmaceuticals, EnVivo Pharmaceuticals, SAI Life Sciences, and WuXiAppTec, and earned a PhD in Organic Chemistry from the University of Wisconsin-Madison followed by postdoctoral research in the laboratory of Nobel laureate K. Barry Sharpless.
AD
Ann DeWittNamed on SEC filing
JR
John RippleNamed on SEC filing
Investors · 2
Breakthrough Energy VenturesreportedBoston · $500K – $50M
How we know: a partner's Signal profile · Not right? Tell us
Safar PartnersreportedCambridge
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$28.6M disclosed across 3 rounds · 2019–2023
▶$10.6MraisedMay 2024 · 6 investors · PharmaceuticalsRule 506(b)
▶$10.6MraisedMay 2024 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Rachel ShaDirector
- Robert Michael PooleDirector
- Amy RipkaExecutive Officer, Director
- John RippleDirector
- Offering amount
- $10.6M
- Amount sold
- $10.6M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15MraisedJan 2022 · 5 investors · PharmaceuticalsRule 506(b)
▶$15MraisedJan 2022 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- John RippleDirector
- Amy RipkaExecutive Officer, Director
- Karoly NikolichDirector
- Ann DeWittDirector
- Offering amount
- $20M
- Amount sold
- $15M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$3MraisedJul 2020 · 4 investors · PharmaceuticalsRule 506(b)
▶$3MraisedJul 2020 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Amy RipkaExecutive Officer, Director
- Ann DeWittDirector
- John RippleDirector
- Offering amount
- $4.5M
- Amount sold
- $3M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Lucy Therapeutics went on to found or lead other companies.
Frequently asked questions
- Who founded Lucy Therapeutics?
- Lucy Therapeutics was founded by Amy Ripka in 2017.
- Who are Lucy Therapeutics's investors?
- Lucy Therapeutics's investors include Breakthrough Energy Ventures, Safar Partners.
- How much funding has Lucy Therapeutics raised?
- Lucy Therapeutics has disclosed $28.6M raised across 3 rounds.
- Where is Lucy Therapeutics headquartered?
- Lucy Therapeutics is headquartered in Cambridge, US.